DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD0641568
Title:
METHIONINE-PYRIDOXINE AND AIRSICKNESS.
Descriptive Note:
Final rept., Jul 63-Sep 65,
Corporate Author:
SCHOOL OF AEROSPACE MEDICINE BROOKS AFB TEX
Report Date:
1966-10-01
Pagination or Media Count:
11.0
Abstract:
The paper presents two observations made incidental to a series of unsuccessful experiments which were designed to study individual variation of response to stimuli intended to induce airsickness. The first observation suggests that capsules containing 50 mg. 1-methionine and 50 mg. pyridoxine, when administered initially and midway during a 4-hour flight, have a limited ability to protect human volunteers against motion sickness. The second observation identifies a structural similarity between the therapeutically effective antimotion sickness agents, neurochemical transmitters, and the peptide linkage. Author
Distribution Statement:
APPROVED FOR PUBLIC RELEASE